A comparison of subjective clinical and objective judgement of abdominal aortic aneurysm morphology

2021 ◽  
Vol 40 (2) ◽  
Author(s):  
Kazumasa HANADA ◽  
Katsuyuki HOSHINA ◽  
Takumi IWAKIRI ◽  
Takafumi AKAI ◽  
Kazuhiro MIYAHARA ◽  
...  
1994 ◽  
Vol 163 (5) ◽  
pp. 1123-1129 ◽  
Author(s):  
C L Siegel ◽  
R H Cohan ◽  
M Korobkin ◽  
M B Alpern ◽  
D L Courneya ◽  
...  

2001 ◽  
Vol 33 (2) ◽  
pp. 1-10 ◽  
Author(s):  
Rodney A. White ◽  
Carlos E. Donayre ◽  
Irwin Walot ◽  
Jonathan Woody ◽  
Namil Kim ◽  
...  

Circulation ◽  
2013 ◽  
Vol 128 (11_suppl_1) ◽  
pp. S163-S174 ◽  
Author(s):  
M. Salmon ◽  
W. F. Johnston ◽  
A. Woo ◽  
N. H. Pope ◽  
G. Su ◽  
...  

VASA ◽  
2005 ◽  
Vol 34 (4) ◽  
pp. 217-223 ◽  
Author(s):  
Diehm ◽  
Schmidli ◽  
Dai-Do ◽  
Baumgartner

Abdominal aortic aneurysm (AAA) is a potentially fatal condition with risk of rupture increasing as maximum AAA diameter increases. It is agreed upon that open surgical or endovascular treatment is indicated if maximum AAA diameter exceeds 5 to 5.5cm. Continuing aneurysmal degeneration of aortoiliac arteries accounts for significant morbidity, especially in patients undergoing endovascular AAA repair. Purpose of this review is to give an overview of the current evidence of medical treatment of AAA and describe prospects of potential pharmacological approaches towards prevention of aneurysmal degeneration of small AAAs and to highlight possible adjunctive medical treatment approaches after open surgical or endovascular AAA therapy.


Sign in / Sign up

Export Citation Format

Share Document